- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
When comparing the attitude of millennials – defined as 18 – 34 year olds – with older generations’ concerns about sun damage, the research found that 81% of millennials expressed concern over sun damage, compared to less than three-quarters (74%) of over-35s, from the region. Matthew Perry, Associate Analyst, at GlobalData explains: “While the negative […]
Artificial Intelligence (AI) is more important to IoT than Big Data insights, says GlobalData
For enterprise software, operational efficiency trumps superfluous features. When it comes to optimising these applications, however, particularly for the Internet of Things (IoT), enterprises need to focus their efforts on the basics of business optimization rather than insight driven innovation. A recent GlobalData survey of 1,000 IoT professionals revealed a heavy reliance on traditional business […]
NASH webinar- Understand the NASH Market Landscape
Affecting more than 60 million people worldwide, and with no approved therapies, nonalcoholic steatohepatitis (NASH) presents a wealth of opportunities for drug developers. Join GlobalData's webinar "Understand the NASH Market Landscape" July 12th.
Asia-Pacific drug delivery devices market set to leave North America behind by 2026
The drug delivery devices market in North America (United States, Canada and Mexico), which comprises approximate 50% of the global market, grew at a compound average growth rate (CAGR) of 2.6% from 2010 to 2016. However, the Asia-Pacific (APAC) region showed a highest growth with a CAGR of 3.4% during the same period, according to GlobalData, a recognized leader in providing business information and analytics.
With pharma industry ROI down, opportunity lies with innovative development and market access strategy
The pharmaceutical industry is driven by innovation in drug discovery. The age of the blockbuster drug looks to have ended, with the return on R&D spend having declined 6.4% between 2010 and 2016, according to GlobalData’s Pharmaceutical Products Database.
Expansion of FinTech in Private Banking
FinTech companies are beginning to make their mark on the global financial services market.
Chinese companies on the rise in 2016 Global Private Wealth Managers AUM Ranking from GlobalData and Private Banker International
The world’s 25 largest private wealth managers grew their assets under management (AUM) by 5.5% in 2016, compared to a growth rate of 2.9% a year previously, according to the Global Private Wealth Managers AUM Ranking revealed by research and consulting firm GlobalData and Private Banker International.
Private bankers can’t ignore mass affluent segment
Wealth managers need to start thinking about the source of future income by paying attention to the inheritors of the wealth.
BIO Webinar- Pharma Trends in Emerging Markets
Slow growth in pharmaceutical sales over recent years has spurred considerable interest and investment into emerging global markets: Brazil, Russia, India, China and South Korea (BRICS).
The importance of megacities in the contemporary economy
As the urban population continues to increase, there is a significant increase in the number of ‘megacities’ on the planet. GlobalData’s latest city data reveals that in 2025 there will be 41 megacities globally, including 12 in China and six in India.